Valuation : Becton, Dickinson and Company

Market Cap 50.97B 43.97B 41.42B 37.74B 70.54B 4,815B 71.07B 490B 190B 2,462B 191B 187B 8,086B P/E 2026 *
36.1x
P/E 2027 * 20.1x
Enterprise Value 66.85B 57.67B 54.33B 49.5B 92.53B 6,315B 93.22B 643B 250B 3,229B 251B 246B 10,607B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.29x
Free-Float
73.18%
Yield 2026 *
2.1%
Yield 2027 * 2.13%
1 day+1.50%
1 week-0.15%
Current month+0.97%
1 month+11.59%
3 months+31.50%
6 months+7.58%
Current year-2.13%
1 week 186.48
Extreme 186.48
191.76
1 month 166.8
Extreme 166.8
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
278.45
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
8/13/26 Exercice

Chief Executive Officer

129,834 0.0471%
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%-0.15%+0.95%-30.40% 50.97B
+2.64%-1.91%-14.86%+10.95% 188B
+1.63%+1.85%+0.42%+16.86% 118B
+1.75%+2.87%+14.36%+95.05% 63.16B
-1.89%-2.30%+26.76%+50.42% 52.01B
+0.07%+1.30%+21.29%-10.18% 34.02B
+3.02%+4.70% - - 30.8B
+0.83%-2.65%+39.76%-15.61% 23.83B
-2.97%-4.91%-7.98%+11.64% 23.45B
+2.05%-0.98%-3.13%+4.83% 22.39B
Average +0.87%-1.78%+8.62%+14.84% 60.69B
Weighted average by Cap. +1.45%-2.62%+1.75%+18.73%

Financials

2026 *2027 *
Net sales 19.29B 16.64B 15.68B 14.28B 26.7B 1,822B 26.9B 186B 72.03B 932B 72.44B 70.86B 3,061B 19.73B 17.02B 16.04B 14.61B 27.31B 1,864B 27.52B 190B 73.68B 953B 74.1B 72.48B 3,131B
Net income 1.44B 1.24B 1.17B 1.06B 1.99B 136B 2B 13.82B 5.36B 69.39B 5.39B 5.28B 228B 2.34B 2.02B 1.9B 1.73B 3.24B 221B 3.26B 22.51B 8.74B 113B 8.79B 8.59B 371B
Net Debt 15.88B 13.7B 12.91B 11.76B 21.98B 1,501B 22.15B 153B 59.31B 767B 59.65B 58.35B 2,520B 13.95B 12.04B 11.34B 10.33B 19.31B 1,318B 19.45B 134B 52.1B 674B 52.39B 51.24B 2,213B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-02 $189.81 +1.43% 437,770
26-09-01 $187.12 -0.53% 1,279,742
26-08-31 $188.11 -0.74% 2,629,617
26-08-28 $189.52 +0.74% 1,693,786
26-08-27 $188.13 -1.09% 1,354,083
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
187.12USD
Average target price
195.67USD
Spread / Average Target
+4.57%

Quarterly revenue - Rate of surprise